Literature DB >> 17953099

Outbreak of sporotrichosis, Western Australia.

Kynan T Feeney1, Ian H Arthur, Amanda J Whittle, Shelley A Altman, David J Speers.   

Abstract

A cluster of sporotrichosis cases occurred in the Busselton-Margaret River region of Western Australia from 2000 to 2003. Epidemiologic investigation and mycologic culture for Sporothrix schenckii implicated hay initially distributed through a commercial hay supplier as the source of the out-break. Declining infection rates have occurred after various community measures were instigated.

Entities:  

Mesh:

Year:  2007        PMID: 17953099      PMCID: PMC2828077          DOI: 10.3201/eid1308.061462

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Sporotrichosis is an infection caused by the fungal species Sporothrix schenckii. It predominantly causes subacute to chronic subcutaneous infection, which occurs when the fungus enters small breaks in the skin (). S. schenckii is widely found on organic material in the environment such as sphagnum moss, fruits, and plants. Human cases have been reported from intermediate hosts; cats were the source of an outbreak in Rio de Janeiro (–). Outbreaks in Australia and other countries have been previously linked to contact with hay (,). In Western Australia, sporadic cases have occurred for many years in the southwest, particularly in the wheat-growing areas (Figure 1), but in the year 2000 an increase in the number of cases of sporotrichosis was noted (). Forty-one microbiologically confirmed human cases were reported from 2000 to 2003 compared with 8 cases from 1997 to 1999 at the PathWest Laboratory at QEII Medical Centre, which has branches throughout metropolitan and regional Western Australia. A review of these cases found that 22 cases were from the Busselton-Margaret River (BMR) region of Western Australia, where no cases had previously been recorded.
Figure 1

Wheat-growing region and Busselton-Margaret River region of Western Australia.

Wheat-growing region and Busselton-Margaret River region of Western Australia.

The Study

An epidemiologic study was begun in 2003 to determine the nature and source of the infection. Pathology laboratories and general practitioners in the southwest region of Western Australia were contacted to ascertain patients with cases of sporotrichosis, defined as clinical evidence of disease supported by microbiologic confirmation. Telephone interviews, which included questions on possible sources of infection, were conducted with all identified patients. The epidemiologic study (Table 1) discovered 11 patients with a microbiologic diagnosis of sporotrichosis from July 2003 to July 2004 in the southwest region. All lived in the BMR region except for 2 (patients 3 and 5).
Table 1

Sporotrichosis cases in Western Australia, July 2003–July 2004

Patient no.SexAge, yArea of residencePre-existing cutsOnset of symptoms, mo/yDuration of disease, moAntifungal treatmentSuspected exposure*GenBank accession no.
1F57BMR†Present7/036Surgery, oral traconazole,
oral K‡Camping trip in a different region of AustraliaEF589115
2M48BMRPresent10/035Oral traconazoleHay (2)EF589117
3M68GreenbushesPresent11/034Oral traconazoleGardeningEF589116
4F39BMRPresent12/034Oral traconazoleHay (1)EF589119
5M65ColliePresent12/034Oral traconazoleHay (own supply)Not available
6M56BMRAbsent12/034Oral traconazoleHay (1)EF589121
7F69BMRAbsent1/042Oral traconazoleHay (1)EF589118
8M66BMRAbsent1/043.5Oral traconazoleHay (2)EF589120
9M10BMRPresent2/042Surgery, oral traconazoleHay (1)EF589122
10F8BMRPresent7/045Oral traconazoleHay (1)EF589124
11F3BMRPresent7/045Naturopathic treatmentHay (1)EF589123

*1 and 2 refer to outlet 1 and 2, respectively.
†Busselton-Margaret River region.
‡Saturated solution of potassium iodide.

*1 and 2 refer to outlet 1 and 2, respectively.
†Busselton-Margaret River region.
‡Saturated solution of potassium iodide. Nine of the 11 case-patients had contact with hay preceding the development of sporotrichosis; 8 had bought the hay from 1 of 2 commercial suppliers located in the township of Margaret River (outlet 1 and outlet 2). The remaining patient had contact with hay grown on his property. Seven of the 9 persons with cases linked to hay exposure had used the hay for domestic gardening; the other 2 patients were exposed to hay used for commercial farming. Patients 10 and 11 were children who played together in hay purchased from outlet 1 before the onset of symptoms of sporotrichosis. Patients 1 and 3 had no documented hay exposure; sporotrichosis developed after a camping trip and after gardening, respectively. Nine case-patients were initially treated with oral antimicrobial agents for a presumed bacterial infection. Because of a lack of clinical response, wound swabs or biopsy specimens were obtained. Sporotrichosis was subsequently diagnosed, and antifungal therapy was then begun. Four patients required inpatient treatment for 1 of several reasons: initially to receive intravenous antimicrobial agents before the diagnosis, to undergo debridement surgery and biopsy, or to treat complications related to therapy. Ten of the 11 patients received oral itraconazole; 1 of these patients also received a saturated solution of potassium iodide, and 1 patient ceased oral antifungal therapy because of severe side effects. One of the 11 received only a naturopathic remedy. When hay was implicated as a likely source, local environmental health officers visited commercial hay outlets in the area to assess procurement, storage, and distribution practices. Fifty hay samples were collected from around the BMR region for mycologic culture. Sixteen samples were from properties associated with 6 of the cases, 9 from the 2 commercial hay outlets, 7 from a farm that supplied hay to a commercial outlet, and 18 from other properties in the BMR region not associated with the outbreak (control samples). Mycologic culture for organisms from the Ophiostoma–Sporothrix complex was performed on a portion of each hay sample. Isolates were examined for morphologic features and analyzed by pulsed-field gel electrophoresis (PFGE) (). Sequencing the ITS1 region with universal primers ITS1 and ITS2 and the ITS2 region with universal primers ITS3 and ITS4 was performed with Applied Biosystems BigDye Terminator v3.1 Cycle Sequencing reagent using the Applied Biosystems Prism 3100 Avant Genetic Analyzer (Foster City, CA, USA). Using ITS sequencing, de Beer et al. () distinguished clinical strains of S. schenckii from environmental strains. Isolates positive for the clinical group of S. schenckii showed morphologic features of conidia that are predominantly oval and display sleeves of dematiaceous conidia along the hyphae. When BLAST software (www.ncbi.nlm.nih.gov/blast) was used, these isolates had ITS2 sequences that conform to the clinical group noted by de Beer et al. (). They differ from Western Australian environmental isolates of the Opiostoma–Sporothrix complex obtained in this study and clinical S. schenckii isolates from the eastern states of Australia in their morphologic features, PFGE patterns (), and ITS2 sequences (data not shown). Of the 6 case-patient–related properties from which environmental samples were taken (Table 2), 3 had a single sample that was culture positive for S. schenckii (clinical strain). Each of these 3 patients had purchased hay from the same commercial hay outlet (outlet 1). One of the hay samples from outlet 1 was also culturally positive for S. schenckii clinical group. These 4 isolates had identical ITS2 sequences and morphologic features that were similar to all our patient isolates available for testing (the patient 5 isolate was not available). S. schenckii (clinical strain) was not isolated from any of the control hay samples, although other members of the Opiostoma–Sporothrix complex were isolated in many environmental samples.
Table 2

Culture findings from environmental sampling

Hay sample sourceNo. samplesSamples culture positive for Sporothrix schenckii* (GenBank accession no.)
Hay used by case-patient 220
Hay used by case-patient 421 (EF589128)
Hay used by case-patient 631 (EF589126)
Hay used by case-patient 740
Hay used by case-patient 831 (EF589125)
Hay used by case-patient 920
Hay outlet 151 (EF589127)
Hay outlet 240
Source of outlet 170
Control samples180

*S. schenckii clinical group as described in text.

*S. schenckii clinical group as described in text.

Conclusions

The epidemiologic aspect of our study implicated contaminated hay as the source of an outbreak of sporotrichosis in the BMR region. Exposure was documented for 9 of the 11 case-patients. Most patients described contact with hay during gardening. Eight patients had contact with hay purchased at commercial suppliers in the Margaret River region. Mycologic culture of hay samples confirmed that the hay was a possible source of infection. Half of the case-related properties tested were culture positive for the clinical strain of S. schenckii, as was a sample from a commercial hay supplier that had supplied hay to these properties. None of the control samples or samples from a farm that supplied hay to this hay supplier showed S. schenckii (clinical strain) on mycologic culture. All Western Australia clinical isolates tested—including the BMR outbreak isolates, the isolates from the hay supplier, and 3 case-related hay samples—are indistinguishable by ITS2 sequencing and PFGE. These isolates differ from the environmental isolates of the Ophiostoma–Sporothrix complex tested from our survey and from eastern states’ clinical isolates. Therefore, the epidemiologically implicated hay from the commercial hay suppliers was considered the likely source of the regional outbreak. This finding prompted intervention in the community. Commercial hay suppliers cooperated by destroying any moldy hay on their properties and storing hay awaiting sale on rubber matting under cover. Information about the diagnosis and management of the infection was distributed to general practitioners in the area, and general information was distributed to the community through various sources such as community newspapers. Since the initial outbreak of sporotrichosis in the BMR region, the infection rate has decreased (Figure 2). Further distribution of the organism by hay suppliers across the region appears to have ceased with the introduction of infection control measures.
Figure 2

Sporotrichosis clinical isolation data from PathWest (QEII), July 1996–June 2006. BMR, Busselton-Margaret River.

Sporotrichosis clinical isolation data from PathWest (QEII), July 1996–June 2006. BMR, Busselton-Margaret River.
  7 in total

Review 1.  Sporotrichosis.

Authors:  T De Araujo; A C Marques; F Kerdel
Journal:  Int J Dermatol       Date:  2001-12       Impact factor: 2.736

Review 2.  Spook house sporotrichosis. A point-source outbreak of sporotrichosis associated with hay bale props in a Halloween haunted-house.

Authors:  D P Dooley; P S Bostic; M L Beckius
Journal:  Arch Intern Med       Date:  1997-09-08

3.  Macrorestriction analysis of clinical and environmental isolates of Sporothrix schenckii.

Authors:  L C O'Reilly; S A Altman
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Phylogeny of the Ophiostoma stenoceras-Sporothrix schenckii complex.

Authors:  Z Wilhelm de Beer; Thomas C Harrington; Hester F Vismer; Brenda D Wingfield; Michael J Wingfield
Journal:  Mycologia       Date:  2003 May-Jun       Impact factor: 2.696

5.  Epidemic cutaneous sporotrichosis: report of 16 cases in Queensland due to mouldy hay.

Authors:  S Conias; P Wilson
Journal:  Australas J Dermatol       Date:  1998-02       Impact factor: 2.875

6.  Sporotrichosis with widespread cutaneous lesions: report of 24 cases related to transmission by domestic cats in Rio de Janeiro, Brazil.

Authors:  Mônica Bastos de Lima Barros; Armando de Oliveira Schubach; Maria Clara Gutierrez Galhardo; Tânia Maria Pacheco Schubach; Rosani Santos dos Reis; Maria José Conceição; Antônio Carlos Francesconi do Valle
Journal:  Int J Dermatol       Date:  2003-09       Impact factor: 2.736

7.  A multistate outbreak of sporotrichosis associated with sphagnum moss.

Authors:  F B Coles; A Schuchat; J R Hibbs; S F Kondracki; I F Salkin; D M Dixon; H G Chang; R A Duncan; N J Hurd; D L Morse
Journal:  Am J Epidemiol       Date:  1992-08-15       Impact factor: 4.897

  7 in total
  9 in total

1.  Epidemiological findings and laboratory evaluation of sporotrichosis: a description of 103 cases in cats and dogs in southern Brazil.

Authors:  Isabel Martins Madrid; Antonella Souza Mattei; Cristina Gevehr Fernandes; Márcia de Oliveira Nobre; Mário Carlos Araújo Meireles
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

2.  Case report: Sporotrichosis from the Northern Territory of Australia.

Authors:  Shradha Subedi; Sarah E Kidd; Robert W Baird; Nicholas Coatsworth; Anna P Ralph
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

Review 3.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

4.  Lymphocutaneous sporotrichosis in an immunocompetent patient: a case report from extreme southern Italy.

Authors:  Giuseppe Criseo; Giovanna Malara; Orazio Romeo; Antonio Puglisi Guerra
Journal:  Mycopathologia       Date:  2008-04-18       Impact factor: 2.574

5.  Comparative genomics of the major fungal agents of human and animal Sporotrichosis: Sporothrix schenckii and Sporothrix brasiliensis.

Authors:  Marcus M Teixeira; Luiz G P de Almeida; Paula Kubitschek-Barreira; Fernanda L Alves; Erika S Kioshima; Ana K R Abadio; Larissa Fernandes; Lorena S Derengowski; Karen S Ferreira; Rangel C Souza; Jeronimo C Ruiz; Nathalia C de Andrade; Hugo C Paes; André M Nicola; Patrícia Albuquerque; Alexandra L Gerber; Vicente P Martins; Luisa D F Peconick; Alan Viggiano Neto; Claudia B Chaucanez; Patrícia A Silva; Oberdan L Cunha; Fabiana F M de Oliveira; Tayná C dos Santos; Amanda L N Barros; Marco A Soares; Luciana M de Oliveira; Marjorie M Marini; Héctor Villalobos-Duno; Marcel M L Cunha; Sybren de Hoog; José F da Silveira; Bernard Henrissat; Gustavo A Niño-Vega; Patrícia S Cisalpino; Héctor M Mora-Montes; Sandro R Almeida; Jason E Stajich; Leila M Lopes-Bezerra; Ana T R Vasconcelos; Maria S S Felipe
Journal:  BMC Genomics       Date:  2014-10-29       Impact factor: 3.969

6.  Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory, Australia.

Authors:  Sarah L McGuinness; Rowena Boyd; Sarah Kidd; Charlie McLeod; Vicki L Krause; Anna P Ralph
Journal:  BMC Infect Dis       Date:  2016-01-13       Impact factor: 3.090

7.  An atypical cause of sporotrichosis in a cat.

Authors:  Jeffrey Thomson; Darren J Trott; Richard Malik; Bradley Galgut; Milton M McAllister; Judith Nimmo; Doug Renton; Sarah E Kidd
Journal:  Med Mycol Case Rep       Date:  2019-01-16

8.  Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks.

Authors:  Anderson Messias Rodrigues; Marcus de Melo Teixeira; G Sybren de Hoog; Tânia Maria Pacheco Schubach; Sandro Antonio Pereira; Geisa Ferreira Fernandes; Leila Maria Lopes Bezerra; Maria Sueli Felipe; Zoilo Pires de Camargo
Journal:  PLoS Negl Trop Dis       Date:  2013-06-20

9.  Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports.

Authors:  Y Zhang; F Hagen; B Stielow; A M Rodrigues; K Samerpitak; X Zhou; P Feng; L Yang; M Chen; S Deng; S Li; W Liao; R Li; F Li; J F Meis; J Guarro; M Teixeira; H S Al-Zahrani; Z Pires de Camargo; L Zhang; G S de Hoog
Journal:  Persoonia       Date:  2015-01-29       Impact factor: 11.051

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.